LAUSR

Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin‐induced pulmonary fibrosis by inhibiting TGF‐&bgr;1/Smad2 pathways and overexpression of NOX4

Sign Up to like & get
recommendations!
0 Published in 2017 at "International Immunopharmacology"

DOI: 10.1016/j.intimp.2017.04.024

Abstract: Abstract Pulmonary fibrosis, a progressive and lethal lung disease, is a major therapeutic challenge for which new therapeutic strategies are warranted. Schisandrin B (Sch B) and Glycyrrhizic acid (GA) are the principal active ingredients of… read more here.

Keywords: induced pulmonary; pulmonary fibrosis; blm; tgf bgr ... See more keywords